Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Paragon 28 Inc (NY: FNA )

6.740 -0.360 (-5.07%)
Official Closing Price Updated: 4:10 PM EDT, Jun 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 504,492
Open 7.030
Bid (Size) 6.620 (1)
Ask (Size) 7.240 (3)
Prev. Close 7.100
Today's Range 6.660 - 7.150
52wk Range 6.960 - 18.99
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What Analysts Are Saying About Paragon 28 Stock
Via Benzinga
FNA Stock Earnings: Paragon 28 Misses EPS, Beats Revenue for Q1 2024
FNA stock results show that Paragon 28 missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace

Performance

YTD
-45.43%
-45.43%
1 Month
-35.99%
-35.99%
3 Month
-41.59%
-41.59%
6 Month
-40.41%
-40.41%
1 Year
-63.92%
-63.92%

More News

Read More
Paragon 28 Reports First Quarter 2024 Financial Results and Reaffirms 2024 Net Revenue Guidance
From Paragon 28, Inc.
Via Business Wire
Paragon 28 to Present at the Bank of America Securities 2024 Healthcare Conference
From Paragon 28, Inc.
Via Business Wire
Unveiling 4 Analyst Insights On Paragon 28
Via Benzinga
Recap: Paragon 28 Q4 Earnings
Via Benzinga
Earnings Scheduled For February 29, 2024
Via Benzinga
Earnings Outlook For Paragon 28
Via Benzinga
Lamb Weston Reports Weak Earnings, Joins Paragon 28, Resources Connection And Other Big Stocks Moving Lower On Thursday
Via Benzinga
Topics Stocks
Exposures US Equities
Paragon 28 Announces CFO Transition, Provides Preliminary Unaudited Net Revenue for First Quarter 2024, and Reaffirms Net Revenue Guidance for Fiscal Year 2024
From Paragon 28, Inc.
Via Business Wire
Paragon 28 Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler® R3INFORCE™ Extraosseous Repair System
From Paragon 28, Inc.
Via Business Wire
Around $9M Bet On Cardlytics? Check Out These 4 Stocks Insiders Are Buying
Via Benzinga
Paragon 28 Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Net Revenue Guidance
From Paragon 28, Inc.
Via Business Wire
Paragon 28 to Present at the CG 2024 Musculoskeletal Conference
From Paragon 28, Inc.
Via Business Wire
Paragon 28 To Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
From Paragon 28, Inc.
Via Business Wire
Paragon 28 Launches PRECISION® MIS Bunion System Offering Surgeons a Guided Minimally Invasive Surgical Solution for Treating Patients with Bunions
From Paragon 28, Inc.
Via Business Wire
Paragon 28 Announces the Launch of the FJ2000™ Power Console and Burr System Designed Specifically for Foot and Ankle Procedures
From Paragon 28, Inc.
Via Business Wire
Paragon 28 Launches the Mister Tendon™ Harvester System – The First and Only Minimally Invasive Harvesting System for FHL and FDL Tendon Transfer Procedures
From Paragon 28, Inc.
Via Business Wire
Paragon 28 Announces First Cases and Limited Market Release of the Bun-Yo-Matic™ – A Next Generation Clamp and Cut Guide System for Lapidus Bunion Procedures
From Paragon 28, Inc.
Via Business Wire
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Boeing, Pacific Biosciences of California And Other Big Stocks Moving Lower On Monday
Via Benzinga
Topics Stocks
Exposures US Equities
Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023
From Paragon 28, Inc.
Via Business Wire
Paragon 28 Advances Foot and Ankle Specific Soft Tissue Portfolio with Launch of Grappler® Knotless Anchor System and Innovative Bridgeline™ Tape
From Paragon 28, Inc.
Via Business Wire
Paragon 28 to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Paragon 28, Inc.
Via Business Wire
Paragon 28 Launches BEAST™ Cortical Fibers Expanding its Biologics Portfolio
From Paragon 28, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.